Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Annovis Bio, Inc.ANVS · Entity 7001 | Director | June 10, 2025 | June 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Annovis Bio, Inc.
Report date June 10, 2025 · Filed June 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,305 |
Reported balance
After 2025-06-10 transaction · row 1
1 source rowRow 1 · 2025-06-10 · Grant · Acquired 2,000 · Balance 9,305 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2025 Filed Jun 11, 2025 20:01 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantCommon Stock | 2,000 | $2.95 | $5,900.00 |
DisclosureSEC source: 0001104659-25-058521 · tm2517636-1_4seq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,305 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 19:33 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantCommon Stock | 824 | $6.07 | $5,001.68 |
DisclosureSEC source: 0001104659-23-120305 · tm2331305d6_4seq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,129 Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 21:24 UTC Amendment | Annovis Bio, Inc. ANVS · Entity 7001 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-120765 · tm2331305-12_4aseq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 F1 · kind: This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023. Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:17 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 29,600 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077835 · tm2417696-4_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,600 Underlying: Common Stock · 29,600 shares Expires 2033-11-17 F1 · security: On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. F2 · derivative.exercise_date: The stock option shall vest immediately upon grant date. Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:05 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantCommon Stock | 476 | $12.61 | $6,002.36 |
DisclosureSEC source: 0001104659-23-044203 · tm2312464-2_4seq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:39 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 5,967 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005477 · tm234043-3_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common Stock · 5,967 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:42 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001642 · tm221949-4_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 15:36 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | PurchaseCommon Stock, $0.0001 par value | 500 | $37.61 | $18,805.00 |
DisclosureSEC source: 0001104659-21-108434 · tm2125684d1_4seq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829 Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 22:27 UTC | Annovis Bio, Inc. ANVS · Entity 7001 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $102.85 | $0.00 |
DisclosureSEC source: 0001104659-21-090744 · tm2121908-4_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2031-07-07 F1 · derivative.exercise_date: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.